Michael J. Mc Elhaugh Arbutus Biopharma Corp (ABUS) insider trading activity

ABUS Quotes by TradingView

Michael J. Mc Elhaugh is Interim President & CEO of Arbutus Biopharma Corp. Currently has a direct ownership of 1.48 Million shares of ABUS, which is worth approximately $5.04 Million. The most recent transaction as insider was on Feb 04, 2025, when has been sold 23,790 shares (Common Shares) at a price of $3.28 per share, resulting in proceeds of $78,031. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M
1.58% 3M change
1.58% 12M change
Total Value Held $5.04 Million

Michael J. McElhaugh Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 04 2025
SELL
Open market or private sale
$78,031 $3.28 p/Share
23,790 Reduced 1.58%
1,481,003 Common Shares
Feb 02 2024
SELL
Open market or private sale
$23,478 $2.31 p/Share
10,164 Reduced 0.67%
1,504,793 Common Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
123,800 Added 7.55%
1,514,957 Common Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
83,700 Added 5.68%
1,391,157 Common Shares
Feb 09 2021
SELL
Open market or private sale
$100,000 $5.0 p/Share
20,000 Reduced 1.51%
1,307,457 Common Stock
Dec 14 2020
SELL
Open market or private sale
$200,000 $5.0 p/Share
40,000 Reduced 2.93%
1,327,457 Common Stock
MJM

Michael J. Mc Elhaugh

Interim President & CEO
Warminster, PA

Track Institutional and Insider Activities on ABUS

Follow Arbutus Biopharma Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABUS shares.

Notify only if

Insider Trading

Get notified when an Arbutus Biopharma Corp insider buys or sells ABUS shares.

Notify only if

News

Receive news related to Arbutus Biopharma Corp

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABUS